Clinical Trials

ProofPilot and Inspire join forces to boost clinical trial reach

ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), has partnered with Inspire, the world’s leading online health community and patient engagement platform, to dramatically expand patient recruitment for clinical trials.

ProofPilot’s platform is purpose-built to optimize recruitment and engagement of patients. By joining ProofPilot’s Patient Recruitment Network, Inspire will help activate patients and caregivers from its diverse, global community, empowering them to find the right trials.

The partnership will help to bolster Inspire’s impact by:

  • Expanding opportunities to connect patients in their community with life-advancing clinical trials
  • Providing a world class, end to end digital experience to optimize participation

“The Inspire community is filled with individuals eager to participate in the advancement and transformation of clinical research,” said Brett Kleger, CEO of Inspire. “By partnering with a tech company like ProofPilot, we can seamlessly connect patients to meaningful clinical trial opportunities, allowing us to focus on what we do best – holistic, year-round engagement of our community.”

“At ProofPilot, we’re committed to transforming the clinical trial experience for both sponsors and patients,” said Chris Venezia, CEO of ProofPilot. “Our partnership with Inspire allows us to leverage their extensive patient community to accelerate recruitment and connect patients with life-changing research opportunities. We’re excited to work with Inspire to break down barriers to study participation.”

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related posts

Spaulding Clinical Expands Services to Include ADME Clinical Trials

Business Wire

IQVIA Laboratories Launches Site Lab Navigator with e-Requisition

Business Wire

Tempus announces the GEMINI Non-Small Cell Lung Cancer Study

Business Wire